Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy

38Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Excellent long-term results are observed in patients with clinical stage I high-risk nonseminomatous germ-cell tumors after one cycle of adjuvant modified-BEP chemotherapy.

Cite

CITATION STYLE

APA

Vidal, A. D., Thalmann, G. N., Karamitopoulou-Diamantis, E., Fey, M. F., & Studer, U. E. (2015). Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy. Annals of Oncology, 26(2), 374–377. https://doi.org/10.1093/annonc/mdu518

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free